Behrendt N, Rønne E, Danø K
Finsen Laboratory, Rigshospitalet, Copenhagen O, Denmark.
Biol Chem Hoppe Seyler. 1995 May;376(5):269-79.
Proteolytic degradation processes, resulting from the activation of plasminogen by the specific enzyme, urokinase plasminogen activator (uPA), take place in the extracellular matrix during cancer invasion as well as in tissue remodelling under certain normal-physiological conditions. The uPA receptor, uPAR, is a cell-surface protein which plays an important role in the localization and regulation of these processes. In the present article a number of established conclusions concerning the structure and function of uPAR are presented, and in addition various models are discussed which might explain additional observations for which the mechanisms involved have not yet been clarified experimentally. uPAR is a highly glycosylated, 3-domain protein, anchored in the plasma membrane by a glycolipid moiety. The domain organization is important for efficient ligand-binding, and the NH2-terminal domain is directly involved in the molecular contact with uPA. The receptor binds uPA as well as its proenzyme, pro-uPA, in such a manner that the activation cascade can occur directly on the cell surface. Furthermore, the activation rates are enhanced relative to the situation in solution, probably due to an interplay between uPAR and other, unidentified components. In addition to the function in the regulation of proteolysis, uPAR seems to play a role in internalization processes and in cellular signal transduction and adhesion. A few reagents have been identified which are capable to inhibit the interaction between uPAR and uPA. The growing knowledge on the structure and function of uPAR which is a result of protein chemical analyses, functional studies and analyses of other, interacting components, should help to obtain a better understanding of the regulation of extracellular proteolysis. In conjunction with the continuous identification of inhibitory reagents, this knowledge should open the possibility to interfere with the resulting, degradative events.
由特异性酶尿激酶型纤溶酶原激活剂(uPA)激活纤溶酶原所引发的蛋白水解降解过程,在癌症侵袭过程中的细胞外基质中以及某些正常生理条件下的组织重塑过程中都会发生。uPA受体(uPAR)是一种细胞表面蛋白,在这些过程的定位和调节中起着重要作用。在本文中,介绍了一些关于uPAR结构和功能的既定结论,此外还讨论了各种模型,这些模型可能解释了一些尚未通过实验阐明其机制的其他观察结果。uPAR是一种高度糖基化的三结构域蛋白,通过糖脂部分锚定在质膜上。结构域组织对于有效的配体结合很重要,并且NH2末端结构域直接参与与uPA的分子接触。该受体以这样一种方式结合uPA及其酶原(pro - uPA),使得激活级联反应能够直接在细胞表面发生。此外,相对于溶液中的情况,激活速率有所提高,这可能是由于uPAR与其他未鉴定成分之间的相互作用。除了在蛋白水解调节中的功能外,uPAR似乎还在内化过程、细胞信号转导和黏附中发挥作用。已经鉴定出一些能够抑制uPAR与uPA之间相互作用的试剂。通过蛋白质化学分析、功能研究以及对其他相互作用成分的分析,对uPAR结构和功能的认识不断增加,这应该有助于更好地理解细胞外蛋白水解的调节。结合不断鉴定出的抑制试剂,这些知识应该为干扰由此产生的降解事件提供可能性。